Novartis — Isomorphic Labs AI discovery collaboration (2024)
Isomorphic Labs will discover small-molecule therapeutics against three targets. The deal includes an upfront payment, research funding and contingent milestones.
- Announced
- 7 Jan 2024 1
Contract facts
Source per value- DateDate the contract, order or partnership was announced or agreed, as stated in the cited source (YYYY-MM-DD). Empty when the source gives only a month or a year.
- 2024-01-071
- BuyerThe purchasing organisation or named customer.
- Novartis1
- VendorThe contracting supplier or AI provider, as named in the source.
- Isomorphic Labs1
- SectorGovernment for public-sector buyers (defence, intelligence, civil agencies, health services); Enterprise for companies.
- Enterprise
- Upfront payment $Upfront payment stated for research and licence collaborations.
- $37,500,0001
- Potential milestones $Contingent milestone payments stated for the collaboration, paid only if targets are reached.
- $1,200,000,0001
Sources
- storage.googleapis.com accessed 2026-11-11
Dollar figures are stated in the source’s own currency and are not converted. Read the summary for what a figure covers.
Related contracts
All 87 contracts-
Eli Lilly — Isomorphic Labs AI discovery collaboration (2024)
Eli Lilly and Company · Isomorphic Labs
Undisclosed -
Boehringer Ingelheim — IBM antibody discovery agreement (2023)
Boehringer Ingelheim · IBM
Undisclosed -
Moderna — OpenAI enterprise collaboration (2024)
Moderna · OpenAI
Undisclosed -
Quest Diagnostics — PathAI software and algorithm licensing (2024)
Quest Diagnostics · PathAI
Undisclosed -
Mayo Clinic — Abridge enterprise clinical documentation agreement (2025)
Mayo Clinic · Abridge
Undisclosed
Spot a change?
Amendment, renewal or a figure that moved? Email hello@aicontractstracker.com with the source link and we update this row and its verified date.